Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevan

Showing results (201-210 of 2,076) with videos related to

Pageof 208
Sort By:
The Journal of Investigative Dermatology|May 25, 2007
Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000Kevan G Lewis, Martin A Weinstock
Current Opinion in Neurobiology|June 12, 2010
Current opinion in neurobiology--sensory systemsKevan A C Martin, Kristin Scott
Current Topics in Microbiology and Immunology|June 16, 2010
New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs)Morris E Feldman, Kevan M Shokat
The Journal of Clinical Investigation|May 15, 2026
New and emerging therapies in type 1 diabetes mellitusKevan C Herold, Carmella Evans-Molina
Bulletin of Environmental Contamination and Toxicology|October 1, 1993
Toxicity of diquat pulse exposure to tropical freshwater shrimp (Caridina nilotica, atyidae)S D Kevan, R G Pearson
Annual Review of Biochemistry|May 10, 2011
The evolution of protein kinase inhibitors from antagonists to agonists of cellular signalingArvin C Dar, Kevan M Shokat
Archives of Sexual Behavior|February 10, 2012
A qualitative study of heterosexual women's attempts to renegotiate sexual relationships in the context of severe sexual problemsSharron Hinchliff, Merryn Gott, Kevan Wylie
Perception|May 15, 2010
Spelling and reading: using visual sensitivity to explore shared or separate orthographic representationsKristen Pammer, Ellen Connell, Alison Kevan
Health (London, England : 1997)|June 4, 2009
Holding onto womanhood: a qualitative study of heterosexual women with sexual desire lossSharron Hinchliff, Merryn Gott, Kevan Wylie
Expert Opinion on Biological Therapy|February 13, 2014
Treatment of new onset type 1 diabetes with teplizumab: successes and pitfalls in developmentNalini K Vudattu, Kevan C Herold
Pageof 208

Showing results (201-210 of 2,076) with videos related to

Sort By:
Pageof 208
The Journal of Investigative Dermatology|May 25, 2007
Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000Kevan G Lewis, Martin A Weinstock
Current Opinion in Neurobiology|June 12, 2010
Current opinion in neurobiology--sensory systemsKevan A C Martin, Kristin Scott
Current Topics in Microbiology and Immunology|June 16, 2010
New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs)Morris E Feldman, Kevan M Shokat
The Journal of Clinical Investigation|May 15, 2026
New and emerging therapies in type 1 diabetes mellitusKevan C Herold, Carmella Evans-Molina
Bulletin of Environmental Contamination and Toxicology|October 1, 1993
Toxicity of diquat pulse exposure to tropical freshwater shrimp (Caridina nilotica, atyidae)S D Kevan, R G Pearson
Annual Review of Biochemistry|May 10, 2011
The evolution of protein kinase inhibitors from antagonists to agonists of cellular signalingArvin C Dar, Kevan M Shokat
Archives of Sexual Behavior|February 10, 2012
A qualitative study of heterosexual women's attempts to renegotiate sexual relationships in the context of severe sexual problemsSharron Hinchliff, Merryn Gott, Kevan Wylie
Perception|May 15, 2010
Spelling and reading: using visual sensitivity to explore shared or separate orthographic representationsKristen Pammer, Ellen Connell, Alison Kevan
Health (London, England : 1997)|June 4, 2009
Holding onto womanhood: a qualitative study of heterosexual women with sexual desire lossSharron Hinchliff, Merryn Gott, Kevan Wylie
Expert Opinion on Biological Therapy|February 13, 2014
Treatment of new onset type 1 diabetes with teplizumab: successes and pitfalls in developmentNalini K Vudattu, Kevan C Herold
Pageof 208